Abstract
The helix–loop–helix inhibitor of differentiation and DNA binding (Id1) is well known as an oncogene in various tumors. Although it has been reported that Id1 promotes several oncogenic processes, it is still unclear whether Id1 functions through epigenetic transcriptional regulation. In this study, we examined the effect of Id1 on polycomb group (PcG) proteins, which are crucial epigenetic gene silencers, and found that Id1 regulated the expression of Mel-18 and Bmi-1, both of which belong to polycomb repressive complex 1. We also confirmed that Id1 induced Mel-18 downregulation, which was mediated by the Akt pathway, and consequently upregulated the transcription of its target gene, c-Myc. Using a promoter–reporter, we demonstrated that Id1 regulated Bmi-1 transcription through c-Myc binding to its E-box in the promoter. Finally, we examined the activity of E3 ligase RING1b, whose catalytic activity is increased by binding with the RING finger protein Bmi-1, and found that Id1 overexpression enhanced RING1b E3 ligase activity leading to accumulation of H2A ubiquitination and ubiquitin/proteasome-mediated degradation of geminin. Taken together, our study provided a novel link between Id1 and PcG proteins and suggested that Id1 may contribute to tumor development through PcG-mediated epigenetic regulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bernardi R, Liebermann DA, Hoffman B . (2000). Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation. Oncogene 19: 2447–2454.
Buchwald G, van der Stoop P, Weichenrieder O, Perrakis A, van Lohuizen M, Sixma TK . (2006). Structure and E3-ligase activity of the Ring-Ring complex of polycomb proteins Bmi1 and Ring1b. EMBO J 25: 2465–2474.
Cales C, Roman-Trufero M, Pavon L, Serrano I, Melgar T, Endoh M et al. (2008). Inactivation of the polycomb group protein Ring1B unveils an antiproliferative role in hematopoietic cell expansion and cooperation with tumorigenesis associated with Ink4a deletion. Mol Cell Biol 28: 1018–1028.
Cao R, Tsukada Y, Zhang Y . (2005). Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell 20: 845–854.
Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P et al. (2002). Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298: 1039–1043.
Choi YS, Jeong S . (2005). PI3-kinase and PDK-1 regulate HDAC1-mediated transcriptional repression of transcription factor NF-kappaB. Mol Cells 20: 241–246.
Elderkin S, Maertens GN, Endoh M, Mallery DL, Morrice N, Koseki H et al. (2007). A phosphorylated form of Mel-18 targets the Ring1B histone H2A ubiquitin ligase to chromatin. Mol Cell 28: 107–120.
Gao H, Yu Z, Bi D, Jiang L, Cui Y, Sun J et al. (2007). Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression. Mol Cell Biochem 305: 35–44.
Geng H, Rademacher BL, Pittsenbarger J, Huang CY, Harvey CT, Lafortune MC et al. (2010). ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21. Cancer Res 70: 3239–3248.
Guo WJ, Datta S, Band V, Dimri GP . (2007). Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins. Mol Biol Cell 18: 536–546.
Hattori T, Kitagawa K, Uchida C, Oda T, Kitagawa M . (2003). Cks1 is degraded via the ubiquitin-proteasome pathway in a cell cycle-dependent manner. Genes Cells 8: 889–896.
Jang KS, Han HX, Paik SS, Brown PH, Kong G . (2006). Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer. Cancer Lett 244: 203–210.
Kanno M, Hasegawa M, Ishida A, Isono K, Taniguchi M . (1995). Mel-18, a Polycomb group-related mammalian gene, encodes a transcriptional negative regulator with tumor suppressive activity. EMBO J 14: 5672–5678.
Kim H, Chung H, Kim HJ, Lee JY, Oh MY, Kim Y et al. (2008). Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells. Breast Cancer Res Treat 112: 287–296.
Kim HJ, Chung H, Yoo YG, Kim H, Lee JY, Lee MO et al. (2007). Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha. Mol Cancer Res 5: 321–329.
Kroll KL . (2007). Geminin in embryonic development: coordinating transcription and the cell cycle during differentiation. Front Biosci 12: 1395–1409.
Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A . (2000). Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 407: 592–598.
Li B, Tsao SW, Li YY, Wang X, Ling MT, Wong YC et al. (2009). Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Int J Cancer 125: 2576–2585.
Lin J, Guan Z, Wang C, Feng L, Zheng Y, Caicedo E et al. (2010). Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin Cancer Res 16: 77–87.
Lee JY, Jang KS, Shin DH, Oh MY, Kim HJ, Kim Y et al. (2008). Mel-18 negatively regulates INK4a/ARF-independent cell cycle progression via Akt inactivation in breast cancer. Cancer Res 68: 4201–4209.
Lee JY, Kang MB, Jang SH, Qian T, Kim HJ, Kim CH et al. (2009). Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition. Oncogene 28: 824–831.
Lessard J, Sauvageau G . (2003). Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423: 255–260.
Levine SS, King IF, Kingston RE . (2004). Division of labor in polycomb group repression. Trends Biochem Sci 29: 478–485.
Li B, Cheung PY, Wang X, Tsao SW, Ling MT, Wong YC et al. (2007). Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells. Carcinogenesis 28: 2313–2320.
Li Z, Cao R, Wang M, Myers MP, Zhang Y, Xu RM . (2006). Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complex. J Biol Chem 281: 20643–20649.
Ling MT, Wang X, Zhang X, Wong YC . (2006). The multiple roles of Id-1 in cancer progression. Differentiation 74: 481–487.
Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW et al. (2006). Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063–6071.
Lund AH, van Lohuizen M . (2004). Polycomb complexes and silencing mechanisms. Curr Opin Cell Biol 16: 239–246.
Matsuo F, Yano K, Saito H, Morotomi K, Kato M, Yoshimoto M et al. (2002). Mutation analysis of the mel-18 gene that shows decreased expression in human breast cancer cell lines. Breast Cancer 9: 33–38.
McGarry TJ, Kirschner MW . (1998). Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 93: 1043–1053.
Ohtsubo M, Yasunaga S, Ohno Y, Tsumura M, Okada S, Ishikawa N et al. (2008). Polycomb-group complex 1 acts as an E3 ubiquitin ligase for Geminin to sustain hematopoietic stem cell activity. Proc Natl Acad Sci USA 105: 10396–10401.
Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL et al. (2003). Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423: 302–305.
Saxena S, Dutta A . (2005). Geminin-Cdt1 balance is critical for genetic stability. Mutat Res 569: 111–121.
Seo S, Herr A, Lim JW, Richardson GA, Richardson H, Kroll KL . (2005). Geminin regulates neuronal differentiation by antagonizing Brg1 activity. Genes Dev 19: 1723–1734.
Singh J, Murata K, Itahana Y, Desprez PY . (2002). Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene 21: 1812–1822.
Sparmann A, van Lohuizen M . (2006). Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6: 846–856.
Swarbrick A, Akerfeldt MC, Lee CS, Sergio CM, Caldon CE, Hunter LJ et al. (2005). Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1. Oncogene 24: 381–389.
Tang X, Jang SW, Wang X, Liu Z, Bahr SM, Sun SY et al. (2007). Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation. Nat Cell Biol 9: 1199–1207.
van der Stoop P, Boutsma EA, Hulsman D, Noback S, Heimerikx M, Kerkhoven RM et al. (2008). Ubiquitin E3 ligase Ring1b/Rnf2 of polycomb repressive complex 1 contributes to stable maintenance of mouse embryonic stem cells. PLoS One 3: e2235.
Voncken JW, Roelen BA, Roefs M, de Vries S, Verhoeven E, Marino S et al. (2003). Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition. Proc Natl Acad Sci USA 100: 2468–2473.
Wang H, Wang L, Erdjument-Bromage H, Vidal M, Tempst P, Jones RS et al. (2004). Role of histone H2A ubiquitination in Polycomb silencing. Nature 431: 873–878.
Wei J, Zhai L, Xu J, Wang H . (2006). Role of Bmi1 in H2A ubiquitylation and Hox gene silencing. J Biol Chem 281: 22537–22544.
Zaaroor-Regev D, de Bie P, Scheffner M, Noy T, Shemer R, Heled M et al. (2010). Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome. Proc Natl Acad Sci USA 107: 6788–6793.
Zeller KI, Zhao X, Lee CW, Chiu KP, Yao F, Yustein JT et al. (2006). Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci USA 103: 17834–17839.
Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR . (2000). The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci 113 (Pt 23): 4363–4371.
Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC . (2001). HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 3: 973–982.
Acknowledgements
This work was supported by a Korea Research Foundation Grant (KRF-2007-314-E00041) funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) and a Korea Science and Engineering Foundation grant funded by the Korean government (MEST) (No. 20090081874).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Qian, T., Lee, JY., Park, JH. et al. Id1 enhances RING1b E3 ubiquitin ligase activity through the Mel-18/Bmi-1 polycomb group complex. Oncogene 29, 5818–5827 (2010). https://doi.org/10.1038/onc.2010.317
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.317
Keywords
This article is cited by
-
Context-dependent actions of Polycomb repressors in cancer
Oncogene (2016)
-
Loss of the polycomb protein Mel-18 enhances the epithelial–mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer
Oncogene (2014)
-
Polycomb group proteins and MYC: the cancer connection
Cellular and Molecular Life Sciences (2014)
-
Functional conservation and divergence of J-domain-containing ZUO1/ZRF orthologs throughout evolution
Planta (2014)
-
Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway
Oncogene (2011)